Evidence map›Paper›PMID 41385271›Full record

ReviewCA: a cancer journal for clinicians

Hyperbaric oxygen therapy for chronic radiotherapy-related adverse effects: A clinically focused review.

Cas Stefaan Dejonckheere, Lukas Käsmann, Leonard Christopher Schmeel, Stefanie Walter, Teresa Anzböck, Sven Dreyer, Gustavo Renato Sarria, Eleni Gkika, Julian Philipp Layer

Abstract readReview
In one paragraph

Review in CA: a cancer journal for clinicians. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cas Stefaan DejonckheereDepartment of Radiation Oncology, University Hospital Bonn, Bonn, Germany.ORCID https://orcid.org/0000-0003-4527-4024
Lukas KäsmannDepartment of Radiation Oncology, University Hospital München, Munich, Germany.ORCID https://orcid.org/0000-0001-6260-5249
Leonard Christopher SchmeelDepartment of Radiation Oncology, University Hospital Bonn, Bonn, Germany.ORCID https://orcid.org/0000-0002-3901-4122
Stefanie WalterFederal Association of Laryngeal and Head and Neck Tumors e.V., Bonn, Germany.
Teresa AnzböckDepartment of Gynecology, Division of Gynecological Oncology, University Hospital Bonn, Bonn, Germany.
Sven DreyerDepartment of Orthopedics and Trauma Surgery, Center for Hyperbaric Oxygen Therapy, University Hospital Duesseldorf, Dusseldorf, Germany.
Gustavo Renato SarriaDepartment of Radiation Oncology, University Hospital Bonn, Bonn, Germany.ORCID https://orcid.org/0000-0002-5929-7270
Eleni GkikaDepartment of Radiation Oncology, University Hospital Bonn, Bonn, Germany.ORCID https://orcid.org/0009-0003-7538-9057
Julian Philipp LayerDepartment of Radiation Oncology, University Hospital Bonn, Bonn, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiotherapy is a cornerstone of modern oncologic care, yet its sequelae can significantly impair survivors' quality of life. Chronic radiation-induced conditions-including skin fibrosis, bone necrosis, radiation cystitis, and proctitis-pose substantial challenges for both patients and caregivers, particularly in the context of improving long-term cancer survival. Hyperbaric oxygen therapy, characterized by the promotion of angiogenesis, fibroblast activation, and tissue remodeling in hypoxic environments, has emerged as a potential adjunctive treatment for mitigating these late effects. Herein, the authors critically evaluate randomized trials, cohort studies, and real-world data while highlighting gaps in knowledge, including patient selection, optimal treatment protocols, and long-term outcomes. In addition, they discuss practical considerations and health system implications of the integration of hyperbaric oxygen therapy into survivorship care. The objective of this review is to provide clinicians with an evidence-informed framework to guide decision making in the multidisciplinary management of radiation-related late effects.

Indexed as

Hyperbaric OxygenationNeoplasmsRadiation InjuriesRadiotherapyChronic DiseaseCystitisHumansOsteoradionecrosisProctitisQuality of LifeRandomized Controlled Trials as Topicchronic adverse effectshyperbaric oxygen therapyradiotherapyreviewsurvivorship

Identifiers

PMID41385271
PMCPMC12700310

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.